Nov 17, 2025 08:45AM SeaStar Medical (ICU) Announces Appointment of Michael Messinger as CFO

Sep 29, 2025 08:36AM SeaStar Medical reports survival data for pediatric kidney therapy

Sep 24, 2025 04:28PM SeaStar Medical trial board recommends continuing kidney injury study

Sep 23, 2025 08:24AM SeaStar Medical to present pediatric kidney injury therapy data

Aug 6, 2025 08:33AM SeaStar Medical enrolls 125 patients in kidney injury trial

Jul 22, 2025 08:20AM SeaStar Medical reports 75% survival rate in pediatric kidney injury study

Jul 16, 2025 08:45AM SeaStar Medical adds Texas children's hospital to QUELIMMUNE customer base

Jul 10, 2025 03:30PM SeaStar Medical raises $4 million in registered direct offering

Jul 2, 2025 04:25PM SeaStar Medical (ICU) Announces Positive Nasdaq Listing Determination

Jun 25, 2025 08:05AM SeaStar Medical (ICU) Provides Update on Nasdaq Listing Status

Jun 20, 2025 12:16PM SeaStar Medical (ICU) drops near 50% on public offering

Jun 20, 2025 12:10PM SeaStar Medical (ICU) prices $8 million public offering

Jun 11, 2025 08:28AM SeaStar Medical (ICU) and AREVA Institute announce DoD award, grant for research

May 28, 2025 08:06AM SeaStar Medical (ICU) Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

Apr 8, 2025 08:06AM SeaStar Medical (ICU) Announces FDA Granted Two New Breakthrough Device Designations for SCD Therapy

Jan 31, 2025 08:02AM SeaStar Medical (ICU) Prices 3.53M Share Offering at $1/70/sh

Jan 13, 2025 08:36AM SeaStar Medical (ICU): FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Nov 6, 2024 09:01AM SeaStar Medical (ICU): FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis

Oct 18, 2024 08:31AM SeaStar Medical (ICU) Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis

Oct 8, 2024 08:35AM SeaStar Medical (ICU) Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

Sep 4, 2024 08:34AM SeaStar Medical (ICU) Strengthens Financial Position with Elimination of All Long-Term Debt

Aug 16, 2024 04:36PM SeaStar Medical (ICU) Files for 1.014M Share Offering by Selling Stockholders

Aug 2, 2024 04:09PM SeaStar Medical (ICU) Files for 1.01M Share Offering by Selling Stockholders

Jul 17, 2024 09:05AM Nuwellis (NUWE) Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children’s

Jul 16, 2024 08:33AM SeaStar Medical (ICU): CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal Trial

Jul 10, 2024 09:00AM SeaStar Medical (ICU) Prices 948K Share Offering at $10.55/sh

Jul 3, 2024 08:31AM SeaStar Medical (ICU) Finalizes FDA Labeling Requirement for QUELIMMUNE

Jun 10, 2024 08:32AM SeaStar Medical (ICU) Strengthens Board of Directors